Author

D. Duque

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

A. Tran· 4 shared M. Stuible· 2 shared Y. Durocher· 2 shared A. Diress· 1 shared A.-C. Fluckiger· 1 shared B. A. Harrison· 1 shared B. Akache· 1 shared B. Ontsouka· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. Tran

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Integrated Immunopeptidomics and Proteomics Study Reveals Imbalanced Innate and Adaptive Immune Responses to SARS-Cov-2 Infection

R. Chen, K. M. Fulton, A. Tran, D. Duque, K. Kovalchik, E. Caron, S. M. Twine, J. Li

This study integrates immunopeptidomics and proteomics to show SARS-CoV-2 disrupts antigen presentation and alters HLA protein dynamics in Calu-3 cells.

bioRxiv · Aug 23, 2022 · PreprintImmunology

Intranasal Immunization with a Proteosome-Adjuvanted SARS-CoV2 Spike Protein-Based Vaccine is Immunogenic and Efficacious in Mice & Hamsters

F. C. Stark, B. Akache, L. Deschatelets, A. Tran, M. Stuible, Y. Durocher, M. J. McCluskie, G. Agbayani, R. Dudani, B. A. Harrison, T. M. Renner, S. R. Makinen, J. Bavananthasivam, D. Duque, C. D. Zarley, , J. Zimmermann

This study evaluates an intranasal vaccine formulation containing a proteosome-adjuvanted SARS-CoV-2 Spike protein, showing immunogenicity and efficacy in mice and hamsters against multiple variants.

bioRxiv · Mar 2, 2022 · PreprintImmunology

Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of Concerns

M. A. Rossotti, H. van Faassen, A. Tran, J. Sheff, J. A. Sandhu, D. Duque, M. Hewitt, S. Wen, R. Bavananthasivam, S. Beitari, K. Matte, G. Laroche, P. M. Giguere, C. Gervais, M. Stuible, , J. Tanha

This paper presents a diverse set of nanobodies targeting SARS-CoV-2 spike glycoprotein with broad neutralization activity against multiple variants and high in vivo efficacy.

bioRxiv · Dec 20, 2021 · PreprintBioengineering

An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits potent immunity after a single dose.

A.-C. Fluckiger, B. Ontsouka, J. Bozic, A. Diress, T. Ahmed, T. Berthoud, M. Liao, A. Tran, D. Duque, M. McCluskie, F. Diaz-Mitoma, D. E. Anderson, C. Soare

This paper evaluates an enveloped virus-like particle vaccine, VBI-2902a, which elicits strong immunity against SARS-CoV-2 after a single dose in mice and hamsters.

bioRxiv · Apr 28, 2021Immunology